Work for Axonics Modulation Technologies, Inc.?

Claim Your Profile

Axonics Modulation Technologies, Inc. Logo Image

Axonics Modulation Technologies, Inc.

Axonics Modulation Technologies, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

2019 Annual Report and Form 10K

Axonics Modulation Technologies, Inc.

Axonics Modulation Technologies, Inc. has reached its limit for free report views.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

Archived Annual Reports

  • Axonics Modulation Technologies, Inc.

About Axonics Modulation Technologies, Inc.

201-500 Employees
Based in Irvine, California

Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling.

Ticker:
AXNX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Medical Appliances & Equipment (See More Medical Appliances & Equipment Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol